LRRK2 and Parkinson disease: Relative LRRK2 kinase activity was assessed by normalizing pRab10 MFI to LRRK2 MFI, and this revealed significantly increased stimulation-dependent LRRK2 kinase activity in all monocyte subtypes from early PD and moderate PD groups relative to NHCs (Fig. 8D–F).